{
    "2018-07-10": [
        [
            {
                "time": "",
                "original_text": "贝达药业股东减持117.70万股",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "股东",
                        "减持"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：市场或迎来中级反弹 防御为先医药为上",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业周报",
                        "中级反弹",
                        "防御",
                        "医药"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}